EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity
Cancer Communications · 01.01.2026 · 46
DOI: 10.34133/cancomm.0027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Communications, online erschienen am 14.05.2026. Verfasst von Yunfei Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, P. …. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, P. R. China.
- Institute of Immunology, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, Y., & Cao, X. (2026). EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0027
Vancouver
Zhu Y, Cao X. EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity. Cancer Communications. 2026;46. doi:10.34133/cancomm.0027
BibTeX
@article{Zhu2026,
author = {Zhu, Yunfei and Cao, Xuetao},
title = {EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity},
journal = {Cancer Communications},
year = {2026},
volume = {46},
doi = {10.34133/cancomm.0027}
}
EUVIMED